Alignment Healthcare Inc.

ALHC | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.33

-$0.02 (-0.24%)

At close: Sep 21, 2026, 4:00 PM ET

$8.40

+$0.07 (+0.84%)

Pre-market: Sep 22, 2026, 4:36 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.73B

Enterprise Value $1.04B

Beta 1.11

Average Volume 5.84M

Shares Outstanding (Diluted) 214.37M

Shares Change YoY 2.31%

Institutional Ownership 98.21%

Exchange NASDAQ

ISIN US01625V1044

Price Performance

Price Change 1M -37.5%

Price Change 3M -61.5%

Price Change 6M -52.6%

Price Change YTD -58.8%

Price Change 1Y -51.3%

Price Change 3Y 26.2%

Price Change 5Y -50.5%

1M CAGR (ann.) -37.6%

1Y CAGR (ann.) -49.9%

5Y CAGR (ann.) -14.9%

All-Time CAGR -12.4%

Valuation

PE Ratio 43.84

Forward PE 21.58

PEG Ratio 0.00

Forward PEG 0.30

PS Ratio 0.38

Forward PS 0.30

PB Ratio 6.52

P/FCF Ratio 8.41

P/Adj. FCF Ratio 12.00

P/OCF Ratio 8.41

EV/Sales 0.23

EV/EBIT 80.69

EV/EBITDA 12.03

EV/FCF 5.06

Earnings Yield 2.3%

FCF Yield 11.9%

Adj. FCF Yield 8.3%

Financial Health

Net Cash $687.01M

Total Debt $6.44M

Cash & Short-Term Investments $693.45M

Total Assets $1.28B

Current Ratio 1.70

Quick Ratio 1.70

Debt / Equity Ratio 1.25

Debt / EBITDA 0.07

Debt / FCF 0.03

OCF / Debt 31.90

Interest Coverage 3.39

Altman Z-Score 4.03

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 12.6%

Operating Profit Margin 1.2%

EBITDA Margin 1.9%

Net Profit Margin 0.9%

FCF Margin 4.5%

Adj. FCF Margin 3.1%

SBC / Revenue 1.3%

SBC Impact (per share) -29.9%

Returns

Return on Assets 3.2%

Return on Equity 20.0%

Return on Invested Capital 9.2%

Return on Capital Employed 9.2%

Return on Tangible Assets 3.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 41.3%

Revenue CAGR 5Y 33.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 168.3%

EPS CAGR 5Y 50.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y 61.0%

FCF CAGR 5Y 615.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 16

EPS Growth Next 3Y 75.7%

Revenue Growth Next 3Y 30.7%

Earnings Date Oct 28, 2026

EPS Estimate (next Q) -$0.03

EPS Growth Est (next Q) -250.0%

Revenue Est (next Q) $1.31B

Revenue Growth Est (next Q) 32.1%

Fair Value Estimates

Graham Number $2.34

Graham Upside -71.9%

Lynch Fair Value $4.75

Lynch Upside -43.0%

Price Target $19

Price Target Upside 128.1%

Cash Flow

Operating Cash Flow $205.55M

Free Cash Flow $205.55M

Adj. Free Cash Flow $144.01M

FCF Per Share $0.99

OCF Per Share $0.99

OCF/S Ratio 4.5%

Income Statement

Revenue $4.58B

Gross Profit $248.98M

Operating Income $55M

EBITDA $86.51M

Net Income $40.7M

EPS (Diluted) $0.19

Revenue / Employee $2.48M

Profit / Employee $22.01K

Employees 1,849